A randomised phase II trial of Caelyx®/Doxil® versus doxorubicin in advanced or metastatic soft tissue sarcomas - An EORTC soft tissue and bone sarcoma group trial. - Judson,I.; Radford,J.; Blay,J-Y.; Van Hoesel,Q.; Le Cesne,A.; van Oosterom,A.; Nielsen,O.S.; Kamby,C.; Woll,P.; Harris,M.; Hermans,C.; Donato di Paoloa,E.; et al. (Proceedings of ASCO Volume, 1999)